How is Bradley Pharmaceuticals Inc. organized?
Bradley Pharmaceuticals, Inc. was founded in 1985 as a specialty pharmaceutical company and markets to niche physician specialties in the U.S. and international markets. Bradley’s success is based upon its core strengths in marketing and sales, which enable the company to commercialize brands that fill unmet patient and physician needs, develop new products through life cycle management; and In-License phase II and phase III drugs with long-term intellectual property protection. Bradley Pharmaceuticals Inc. is comprised of: Doak Dermatologics – specializes in therapies for dermatology and podiatry. Kenwood Therapeutics – provides gastroenterology, OBGYN, respiratory and other internal medicine brands. A. Aarons – markets authorized generic versions of Doak and Kenwood therapies. What are the integration teams working on and when do you expect their work to be completed? The integration teams are focused on all key business elements of the new PharmaDerm Division, including research and
